This article was originally published in The Tan Sheet
Executive SummaryThe Netherlands-based DSM Food Specialties, which develops ingredients for the food and beverage industries, strengthens its global position in food enzymes with the acquisition of U.S. biotechnology company Valley Research. Terms of the deal were not disclosed, but the acquisition has been finalized, DSM announces July 11. While strengthening its product portfolio, the deal also allows DSM to "offer regional blending and solution-providing platforms to customers," according to the firm. DSM provides enzymes and other ingredients and to food and beverage firms worldwide...
You may also be interested in...
Eighteen years of free trade threatens to crash, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.